Action Aventis - AVE

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A NEW YORK, Oct. 15...

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers Pre-Booked Customers Received Partial or Full Influenza Vaccine Order...

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease - First Candidate...

Aventis Named to List of Top 100 Companies for Working Mothers

Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21...

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/...

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Diseases WELLESLEY...

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer Earlier use of Taxotere(R) shown to significantly improve...

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adolescents...

Ventiv Health Announces Sales and Marketing Agreement with Aventis

Ventiv Health Announces Sales and Marketing Agreement with Aventis Contract Calls for Over 450 Sales Representatives Focused on Primary Care...

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid) BERWYN, Penn., Aug. 3 /PRNewswire/ -- Dermik Laboratories, the US dermatology arm of...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AVE - Frequently Asked Questions (FAQ)

What is the current Aventis share price?

The current share price of Aventis is US$ 0,00

What is the 1 year trading range for Aventis share price?

Aventis has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
AAMAA Mission Acquisition Corp	US$ 10,23 (0,00%)	0
AACT.UAres Acquisition Corporation II	US$ 11,24 (0,00%)	0
AACTAres Acquisition Corporation II	US$ 11,14 (0,00%)	0
AAAlcoa Corporation	US$ 33,25 (0,00%)	24,7k
AAgilent Technologies	US$ 119,85 (0,00%)	702
AAMAA Mission Acquisition Corp	US$ 10,23 (0,00%)	0
AACT.UAres Acquisition Corporation II	US$ 11,24 (0,00%)	0
AACTAres Acquisition Corporation II	US$ 11,14 (0,00%)	0
AAAlcoa Corporation	US$ 33,25 (0,00%)	24,7k
AAgilent Technologies	US$ 119,85 (0,00%)	702
QBTSD Wave Quantum Inc	US$ 5,82 (0,00%)	6,62M
IONQIonQ Inc	US$ 21,82 (0,00%)	4,49M
NOVASunnova Energy International Inc	US$ 0,3672 (0,00%)	3,18M
PATHUiPath Inc	US$ 11,83 (0,00%)	2,69M
WMTWalmart Inc	US$ 85,20 (0,00%)	2,37M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aventis New Ads (AVE)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

AVE Dernières nouvelles

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease

Aventis Named to List of Top 100 Companies for Working Mothers

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole

Ventiv Health Announces Sales and Marketing Agreement with Aventis

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)

AVE - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aventis New Ads (AVE) Cours

Aventis New Ads (AVE)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

AVE Dernières nouvelles

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease

Aventis Named to List of Top 100 Companies for Working Mothers

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole

Ventiv Health Announces Sales and Marketing Agreement with Aventis

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)

AVE - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE